Cross-fund · 4 holders
BBOT
BRIDGEBIO ONCOLOGY THERAPEUT
CUSIP 107924102 / G4444H101
4
Tracked holders
$53.6M
Aggregate value
5,674,108
Shares
5
Active funds
Funds holding BBOT
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Citadel | Multi-Strategy | Q1 2026 | $22.6M | — | -1,562 | -0.1% |
| BlackRock | Institutional | Q1 2026 | $18.7M | — | +3,460 | +0.2% |
| Vanguard | Institutional | Q4 2025 | $9.9M | — | +143,496 | +22.2% |
| Millennium | Multi-Strategy | Q1 2026 | $2.4M | — | +24,539 | +10.2% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | -23,584 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.